Genetic Technologies Revenue 2010-2022 | GENE

Genetic Technologies revenue from 2010 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Genetic Technologies Annual Revenue
(Millions of US $)
2022 $5
2021 $0
2020 $0
2019 $0
2018 $0
2017 $1
2016 $1
2015 $3
2014 $4
2013 $3
2012 $4
2011 $5
2010 $5
2009 $4
Genetic Technologies Quarterly Revenue
(Millions of US $)
2022-06-30
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2019-06-30
2018-12-31
2018-06-30
2017-12-31
2017-06-30
2016-12-31
2016-06-30
2015-12-31
2015-06-30
2014-12-31
2014-06-30
2013-12-31
2013-06-30
2012-12-31
2012-06-30
2011-12-31
2011-06-30
2010-12-31
2010-06-30
2009-12-31
2009-06-30
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.014B $0.005B
Genetic Technologies was the first company in the world to recognize important new applications for `non-coding` DNA (DeoxyriboNucleic Acid). The Company has since been granted patents securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all multicellular species.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $154.466B 9.42
GSK (GSK) United Kingdom $72.181B 8.99
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.127B 18.99
Ginkgo Bioworks Holdings (DNA) United States $3.783B 0.00
Myovant Sciences (MYOV) United Kingdom $2.614B 0.00
Arcus Biosciences (RCUS) United States $1.566B 23.51
Biohaven (BHVN) United States $1.301B 0.00
Emergent Biosolutions (EBS) United States $0.658B 5.17
ADC Therapeutics SA (ADCT) Switzerland $0.393B 0.00
Ambrx Biopharma (AMAM) United States $0.073B 0.00
Enzo Biochem (ENZ) United States $0.065B 0.00
SQZ Biotechnologies (SQZ) United States $0.024B 0.00
Gelesis Holdings (GLS) United States $0.022B 0.00